Form 4 Tracker
Fady Ibraham Malik

Director; EVP Research & Development · 16 filings · Latest: Oct 6, 2026

CYTOKINETICS INC
ROCKET PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CYTK
Fady Ibraham MalikEVP Research & DevelopmentMay 5, 2026
Sale
$77.373,500$270.8K153,902
CYTK
Fady Ibraham MalikEVP Research & DevelopmentMay 5, 2026
Option Exercise
$7.803,500$27.3K157,402
CYTK
Fady Ibraham MalikEVP Research & DevelopmentApr 21, 2026
Sale
$65.693,500$229.9K153,902
CYTK
Fady Ibraham MalikEVP Research & DevelopmentApr 21, 2026
Option Exercise
$7.803,500$27.3K157,402
CYTK
Fady Ibraham MalikEVP Research & DevelopmentApr 7, 2026
Sale
$65.114,500$293.0K153,902
CYTK
Fady Ibraham MalikEVP Research & DevelopmentApr 7, 2026
Option Exercise
$8.424,500$37.9K154,902
CYTK
FADY MALIK—Apr 7, 2026
Proposed Sale
$64.9422,000$1.4M—
CYTK
Fady Ibraham MalikEVP Research & DevelopmentMar 17, 2026
Sale
$62.1512,033$747.9K153,902
CYTK
Fady Ibraham MalikEVP Research & DevelopmentMar 9, 2026
Sale
$60.722,907$176.5K138,629
CYTK
FADY MALIK—Oct 21, 2025
Proposed Sale
$59.3511,000$652.9K—
CYTK
FADY MALIK—Jul 8, 2025
Proposed Sale
$33.3614,000$467.0K—
CYTK
FADY MALIK—Apr 8, 2025
Proposed Sale
$35.9912,000$431.9K—
CYTK
FADY MALIK—Jan 7, 2025
Proposed Sale
$49.1912,000$590.3K—
CYTK
FADY MALIK—Dec 10, 2024
Proposed Sale
$50.637,300$369.6K—
CYTK
FADY MALIK—Nov 26, 2024
Proposed Sale
$50.167,300$366.2K—
CYTK
FADY MALIK—Nov 12, 2024
Proposed Sale
$58.486,342$370.9K—
CYTK
FADY MALIK—Oct 29, 2024
Proposed Sale
$51.917,300$378.9K—
CYTK
FADY MALIK—Oct 15, 2024
Proposed Sale
$54.197,300$395.6K—
CYTK
FADY MALIK—Oct 1, 2024
Proposed Sale
$52.107,300$380.3K—
CYTK
FADY MALIK—Sep 17, 2024
Proposed Sale
$56.777,300$414.4K—